-+ 0.00%
-+ 0.00%
-+ 0.00%

Truist Securities Maintains Buy on CG Oncology, Raises Price Target to $85

Benzinga·08/07/2026 13:12:30
Listen to the news
Truist Securities analyst Gregory Renza maintains CG Oncology (NASDAQ:CGON) with a Buy and raises the price target from $82 to $85.